Healthcare provider profile · identity verified

James M Santarelli, MD

Family Practice · KENOSHA, WI · NPI 1477660744

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1136	302
Amlodipine Besylate	Amlodipine Besylate	689	189
Levothyroxine Sodium	Levothyroxine Sodium	656	165
Pantoprazole Sodium	Pantoprazole Sodium	584	151
Lisinopril	Lisinopril	459	136
Rosuvastatin Calcium	Rosuvastatin Calcium	421	127
Pravastatin Sodium	Pravastatin Sodium	362	92
Metoprolol Succinate	Metoprolol Succinate	349	86
Losartan Potassium	Losartan Potassium	292	86
Albuterol Sulfate Hfa	Albuterol Sulfate	282	93
Metformin Hcl	Metformin Hcl	258	81
Furosemide	Furosemide	245	76
Omeprazole	Omeprazole	245	79
Allopurinol	Allopurinol	242	68
Simvastatin	Simvastatin	234	63
Hydrochlorothiazide	Hydrochlorothiazide	221	70
Potassium Chloride	Potassium Chloride	208	53
Metoprolol Tartrate	Metoprolol Tartrate	173	43
Jardiance	Empagliflozin	165	47
Escitalopram Oxalate	Escitalopram Oxalate	158	42
Metformin Hcl Er	Metformin Hcl	145	47
Clopidogrel	Clopidogrel Bisulfate	144	41
Valsartan	Valsartan	143	42
Tamsulosin Hcl	Tamsulosin Hcl	142	35
Ezetimibe	Ezetimibe	141	40
Ozempic	Semaglutide	139	43
Sertraline Hcl	Sertraline Hcl	129	28
Prednisone	Prednisone	126	99
Glipizide	Glipizide	122	33
Trazodone Hcl	Trazodone Hcl	114	33
Montelukast Sodium	Montelukast Sodium	113	30
Carvedilol	Carvedilol	110	28
Trulicity	Dulaglutide	109	28
Fluticasone Propionate	Fluticasone Propionate	108	44
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	102	28
Atenolol	Atenolol	100	28
Alendronate Sodium	Alendronate Sodium	98	21
Duloxetine Hcl	Duloxetine Hcl	90	21
Lovastatin	Lovastatin	90	24
Januvia	Sitagliptin Phosphate	87	23
Xarelto	Rivaroxaban	87	20
Citalopram Hbr	Citalopram Hydrobromide	83	25
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	80	16
Hydralazine Hcl	Hydralazine Hcl	77	24
Donepezil Hcl	Donepezil Hcl	75	13
Meloxicam	Meloxicam	70	27
Warfarin Sodium	Warfarin Sodium	68	20
Glipizide Er	Glipizide	65	19
Cefadroxil	Cefadroxil	64	52
Eliquis	Apixaban	61	15
Synthroid	Levothyroxine Sodium	58	18
Doxycycline Hyclate	Doxycycline Hyclate	57	51
Isosorbide Mononitrate Er	Isosorbide Mononitrate	57	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	56	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	55	15
Gabapentin	Gabapentin	55	22
Triamcinolone Acetonide	Triamcinolone Acetonide	52	32
Glimepiride	Glimepiride	50	14
Oxybutynin Chloride Er	Oxybutynin Chloride	48	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	48	16
Famotidine	Famotidine	47	14
Amitriptyline Hcl	Amitriptyline Hcl	45	suppressed
Ondansetron Hcl	Ondansetron Hcl	45	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	44	38
Finasteride	Finasteride	44	11
Bupropion Xl	Bupropion Hcl	42	11
Entresto	Sacubitril/Valsartan	42	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	42	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	42	16
Baclofen	Baclofen	41	15
Fenofibrate	Fenofibrate	40	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	suppressed
Memantine Hcl	Memantine Hcl	40	suppressed
Nystatin	Nystatin	39	21
Diclofenac Sodium	Diclofenac Sodium	38	suppressed
Cefdinir	Cefdinir	37	33
Levetiracetam	Levetiracetam	37	suppressed
Torsemide	Torsemide	37	suppressed
Amoxicillin	Amoxicillin	36	30
Ibuprofen	Ibuprofen	35	13
Benazepril Hcl	Benazepril Hcl	34	11
Fluoxetine Hcl	Fluoxetine Hcl	34	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	34	14
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Propranolol Hcl	Propranolol Hcl	33	suppressed
Enalapril Maleate	Enalapril Maleate	32	suppressed
Ventolin Hfa	Albuterol Sulfate	31	14
Methylprednisolone	Methylprednisolone	30	28
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	29	suppressed
Colchicine	Colchicine	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Folic Acid	Folic Acid	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	13
Gemfibrozil	Gemfibrozil	27	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	27	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	12
Nifedipine Er	Nifedipine	25	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Ranolazine Er	Ranolazine	24	suppressed
Verapamil Er	Verapamil Hcl	24	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	23	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Celecoxib	Celecoxib	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	11
Lamotrigine	Lamotrigine	21	suppressed
Mupirocin	Mupirocin	21	18
Ssd	Silver Sulfadiazine	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Repatha Sureclick	Evolocumab	20	suppressed
Irbesartan	Irbesartan	19	suppressed
Estradiol	Estradiol	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Cephalexin	Cephalexin	17	16
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Cilostazol	Cilostazol	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	15
Ibandronate Sodium	Ibandronate Sodium	16	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Alprazolam	Alprazolam	15	14
Buspirone Hcl	Buspirone Hcl	15	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Niacin Er	Niacin	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	13
Topiramate	Topiramate	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Liothyronine Sodium	Liothyronine Sodium	14	suppressed
Naproxen	Naproxen	14	suppressed
Potassium Citrate Er	Potassium Citrate	14	suppressed
Ramipril	Ramipril	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Trimethoprim	Trimethoprim	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error